Your session is about to expire
← Back to Search
Behavioral Intervention
Self-Monitoring Feedback for Obesity
N/A
Waitlist Available
Led By Kathryn M Ross, PhD, MPH
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
≤ 175 kg (due to scale limit)
Age ≥ 18 years
Must not have
Unwilling to accept random assignment
Medical conditions that contraindicate weight loss or prevent completion of the study (e.g., current diagnosis of cancer or terminal illness, dementia, etc.)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up daily throughout the study period (up to 17 weeks)
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to improve how feedback is given to people who are tracking their weight, food intake, and activity levels in order to help them lose weight. The study will look at the best way to
Who is the study for?
This trial is for individuals looking to manage obesity through weight loss. Participants should be committed to self-monitoring their diet, physical activity, and weight. Specific eligibility criteria are not provided, but typically include being over a certain age and having a body mass index (BMI) that classifies as obese.
What is being tested?
The study tests how different components like diet quality, goal setting, calorie goals, and physical activity affect the success of self-monitoring in treating obesity. It aims to find the best way to provide feedback that encourages adherence to these components.
What are the potential side effects?
Since this trial focuses on lifestyle interventions rather than medication or surgery, side effects may include muscle soreness from increased physical activity or hunger if adjusting to new dietary restrictions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I weigh 175 kg or less.
Select...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am not open to being randomly assigned to a treatment group.
Select...
I do not have any health conditions that prevent me from losing weight or completing a study.
Select...
I cannot or do not want to use the study's smartphone apps, wearables, or e-scale.
Select...
I have lost 10 lbs or more in the last 6 months without trying.
Select...
I cannot walk a quarter mile without stopping due to physical limitations.
Select...
I have had or plan to have weight-loss surgery during the study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ daily throughout the study period (up to 17 weeks)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~daily throughout the study period (up to 17 weeks)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Weight
Secondary study objectives
Calorie Goal Attainment
Feedback Message Acceptability
Frequency of Self-Monitoring Dietary Intake
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Group I: Component 4: Goal SettingExperimental Treatment1 Intervention
Participants will be randomized to either receive or not receive feedback based on weekly goal setting.
Group II: Component 3: Physical Activity Goal AttainmentExperimental Treatment1 Intervention
Participants will be randomized to either receive or not receive feedback based on physical activity goal attainment.
Group III: Component 2: Diet QualityExperimental Treatment1 Intervention
Participants will be randomized to either receive or not receive feedback based on diet quality.
Group IV: Component 1: Calorie Goal AttainmentExperimental Treatment1 Intervention
Participants will be randomized to either receive or not receive feedback based on calorie goal attainment.
Find a Location
Who is running the clinical trial?
University of FloridaLead Sponsor
1,404 Previous Clinical Trials
766,335 Total Patients Enrolled
38 Trials studying Obesity
20,385 Patients Enrolled for Obesity
Kathryn M Ross, PhD, MPHPrincipal InvestigatorUniversity of Florida